You have completed learning Topic 5: Safety Aspects. Remember these key points:

• NuvaRing^® has no clinically relevant effects on a variety of possible risk factors for cardiovascular disease.
• NuvaRing^® produces no significant local effects on cervical or vaginal cytology.

 

 

 

Click HERE to return to the Topic Menu, or click Next to go to the Module 3 Summary.